Arvinas
Develops targeted protein degradation therapies for cancer and neurology.
BiotechnologyPharmaceuticals
Company facts
- Founded
- 2013
- Employees
- 246
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: ARVN
- Subsidiaries
- Oerth Bio
Develops targeted protein degradation therapies for cancer and neurology.
Company facts